However, as shown in the IRF groups, eyes with higher SRF at baseline had a more rapid reduction in RPE volume over the first 12 months (perhaps due to the fact that the SRF protective factor to the RPE atrophy is impacted by the remaining SRF volumes throughout treatment, which are very different from baseline volumes). This evidence concerns the gene SRF and Atrophy.